Drug · DIN 02237154
AMOXICILLIN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since April 27, 2023.
- Drug Identification Number (DIN)
- 02237154
- Company (DIN owner)
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Amoxicillin J01CA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMOXICILLIN | 500 MG | CAP |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 19, 2015: NOC 16621New Drug Submission (NDS) · Transfer of drug identification number
- January 22, 1998: NOC 2702New Drug Submission (NDS)
Other DINs named AMOXICILLIN
- DIN 02352753 · Marketed
- DIN 02352788 · Marketed
- DIN 02401509 · Marketed
- DIN 02401541 · Marketed
- DIN 02352710 · Dormant
- DIN 02352729 · Dormant
- DIN 02352737 · Cancelled Post Market
- DIN 02352745 · Cancelled Post Market
- DIN 02352761 · Cancelled Post Market
- DIN 02401495 · Cancelled Post Market
- DIN 02434709 · Cancelled Pre Market
- DIN 02434717 · Cancelled Pre Market